|国家科技期刊平台
首页|期刊导航|磁共振成像|基于多序列MRI影像组学的胶质母细胞瘤风险分层预测研究

基于多序列MRI影像组学的胶质母细胞瘤风险分层预测研究OA北大核心CSTPCD

Risk stratification prediction of glioblastoma based on multi-sequence MRI radiomics analysis

中文摘要英文摘要

目的 以多序列MRI影像组学方法开发一种胶质母细胞瘤(glioblastoma,GBM)总生存期(overall survival,OS)预测模型,实现风险分层预测.材料与方法 本研究回顾性分析TCIA/TCGA(The Cancer Imaging Archive/The Cancer Genome Atlas)公共数据库中309例GBM患者数据,针对术前对比增强后T1加权(post-contrast enhanced T1-weighted,T1CE)序列和T2加权液体衰减反转恢复(T2-weighted fluid attenuation inversion recovery,T2 FLAIR)序列,提取坏死区、肿瘤区和水肿区三种感兴趣区域的10 128个影像组学特征.采用相关性分析、主成分分析(principal component analysis,PCA)和最小绝对收缩和选择算法-Cox等比例风险回归(least absolute shrinkage and selection operator-cox proportional-hazards,LASSO-Cox),筛选与OS显著相关的影像组学特征,计算风险评分(Risk-score)作为组学标签.采用Kaplan-Meier(KM)生存分析和对数秩(Log-rank)检验比较高、低风险组间的生存差异.应用多因素Cox等比例风险(Cox proportional-hazards,Cox)回归构建临床-影像组学联合模型和列线图.采用一致性指数(concordance index,C-index)评估临床-影像组学联合模型的预测性能,并与临床模型进行比较.结果 根据训练集筛选出的16个影像组学特征计算风险评分,依据风险评分将训练集和测试集患者划分为高、低风险组,Log-rank检验表明高、低风险组患者的生存概率差异具有明显统计学意义.单因素Cox回归确定风险评分、年龄和O6-甲基鸟嘌呤-DNA甲基转移酶(O6-methylguanine-DNA methyltransferase,MGMT)状态是影响GBM总生存期的显著风险因素.多因素Cox回归分别构建临床模型及临床-影像组学联合模型,发现临床-影像组学联合模型性能(训练集:C-index= 0.768,测试集:C-index=0.724)高于影像组学模型(训练集:C-index=0.744,测试集:C-index=0.710)和临床模型(训练集:C-index=0.659,测试集:C-index=0.653).结论 影像组学标签可以作为GBM总生存期的独立预后因素,结合临床病理信息和影像组学标签构建的联合模型能够更好地辅助临床进行GBM风险分层和生存预测,具有重要临床价值.

Objective:To develop a glioblastoma(GBM)overall survival(OS)prediction model using multi-sequence MRI radiomics method.Materials and Methods:This study retrospectively collected data from 309 patients with GBM in the TCIA/TCGA(The Cancer Imaging Archive/The Cancer Genome Atlas)public database,and extracted 10 128 radiomics features from preoperative post-contrast enhanced T1-weighted(T1CE)and T2-weighted fluid attenuation inversion recovery(T2 FLAIR)sequences for three regions of interest:necrosis area,tumor area,and edema area.Correlation analysis,principal component analysis(PCA)for dimensionality reduction,and least absolute shrinkage and selection operator-cox proportional-hazards(LASSO-Cox)regression were used to screen radiomics features significantly related to OS and calculate a Risk-score as a radiomics signature.Kaplan-Meier(KM)survival analysis and Log-rank test were used to compare the survival differences between high-risk and low-risk groups.A clinical-radiomics combined model and nomogram were constructed using multivariate Cox proportional-hazards(Cox)regression and evaluated using concordance index(C-index),which was compared with the clinical model.Results:Based on the 16 radiomics features selected from the training set,a Risk-score was calculated and patients were divided into high-and low-risk groups based on this Risk-score,using both the training and testing sets.Log-rank testing showed a significant difference in survival probability between the high-and low-risk groups.Univariate Cox regression identified Risk-score,age,and O6-methylguanine-DNA methyltransferase(MGMT)status as significant risk factors for OS in GBM.Multivariate Cox regression was used to build clinical model and a clinical-radiomics combined model,and it was found that the clinical-radiomics combined model(training set:C-index=0.768,testing set:C-index=0.724)outperformed the radiomics model(training set:C-index=0.744,testing set:C-index=0.710)and the clinical model(training set:C-index= 0.659,testing set:C-index=0.653).Conclusions:Radiomics signature can serve as independent prognostic factor for OS of GBM,and the combined model constructed by combining clinical pathological information and radiomics signature can better assist in risk stratification and survival prediction of GBM,which holds significant clinical value.

牛文举;徐怀文;高宇翔;王效春;谭艳;张辉;杨国强

山西医科大学医学影像学院,太原 030001山西医科大学第一医院磁共振影像科,太原 030001||山西医科大学医学影像学院,太原 030001

临床医学

胶质母细胞瘤磁共振成像总生存期影像组学预测模型

glioblastomamagnetic resonance imagingoverall survivalradiomicsprediction model

《磁共振成像》 2024 (003)

基于多模态磁共振影像组学构建低级别胶质瘤MGMT启动子甲基化预测模型研究

31-36,42 / 7

National Natural Science Foundation of China(No.U21A20386,81971592);Basic Research Project of Shanxi Province(No.202303021211204). 国家自然科学基金项目(编号:U21A20386、81971592);山西省基础研究计划面上项目(编号:202303021211204)

10.12015/issn.1674-8034.2024.03.006

评论